title: Oral cryotherapy can significantly reduce oral mucositis but not acute GVHD incidence in Flu/Mel conditioning allo-SCT.
authors.forename: S
authors.initials: S
authors.lastname: Vokurka
authors.forename: T
authors.initials: T
authors.lastname: Svoboda
authors.forename: A
authors.initials: A
authors.lastname: Jungova
authors.forename: M
authors.initials: M
authors.lastname: Karas
authors.forename: V
authors.initials: V
authors.lastname: Koza
mesh_terms: D000328:Adult; D000368:Aged; D017679:Cryotherapy / Q000379:methods*; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008558:Melphalan / Q000009:adverse effects*; D008875:Middle Aged; D013280:Stomatitis / Q000517:prevention & control*; D019172:Transplantation Conditioning / Q000009:adverse effects*; D014184:Transplantation, Homologous; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D014740:Vidarabine; C024352:fludarabine; D008558:Melphalan